ALNYLAM PHARMACEUTICALS INC

Ticker: ALNY CUSIP: 02043Q107 Class: EQTY

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 549,922 Value ($000) $218,676 Avg Close $442.56 Range $387.03 - $495.55
Q3 2025
Shares 508,371 Value ($000) $231,817 Avg Close $407.20 Range $309.57 - $484.21
Q2 2025
Shares 238,573 Value ($000) $77,796 Avg Close $276.71 Range $205.87 - $327.21
Q1 2025
Shares 268,932 Value ($000) $72,617 Avg Close $257.00 Range $230.79 - $300.90
Q4 2024
Shares 378,649 Value ($000) $89,100 Avg Close $262.99 Range $229.86 - $304.39
Q3 2024
Shares 63,467 Value ($000) $17,455 Avg Close $260.36 Range $231.01 - $287.55
Q4 2023
Shares 1,300 Value ($000) $249 Avg Close $170.34 Range $148.10 - $198.00
Q2 2023
Shares 11,085 Value ($000) $2,105 Avg Close $198.26 Range $183.00 - $212.47
Q2 2022
Shares 165,292 Value ($000) $24,108 Avg Close $141.87 Range $117.58 - $180.35
Q3 2021
Shares 16,427 Value ($000) $3,102 Avg Close $187.58 Range $166.16 - $209.73
Q2 2020
Shares 58,231 Value ($000) $8,625 Avg Close $134.81 Range $98.01 - $158.37
Q2 2019
Shares 234,539 Value ($000) $17,018 Avg Close $76.72 Range $65.81 - $96.08
Q2 2016
Shares 34,727 Value ($000) $1,927 Avg Close $63.00 Range $49.96 - $75.08
Q2 2014
Shares 5,000 Value ($000) $316 Avg Close $59.44 Range $47.03 - $71.40